HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
August 25, 2003
- JT Positions Pharma Business as Pillar in Next Generation
August 25, 2003
- TRI to Increase Staff Members to 150: Seminar
August 25, 2003
- Wives in Their 20s Having Greater Number of Children: Survey
August 25, 2003
-
August 25, 2003
- PRESS SEMINAR
August 25, 2003
- 31 Mono-drugs, 7 Combination Drugs Designated for Quality Reevaluation
August 25, 2003
- Yamanouchi to Beef Up Marketing to Gain 6% Share: President Takenaka
August 25, 2003
- DIAGNOSTIC NEWS IN BRIEF
August 25, 2003
- 31 Ingredients Designated for 26th Quality Reevaluation
August 25, 2003
- Shionogi Places Top Priority on Proper Use in Marketing Opioids for Cancer Pain
August 25, 2003
- MEDICAL DEVICE NEWS IN BRIEF
August 25, 2003
- Cabinet Office Calls For Lifting of Ban on Medical Services by Non-doctors
August 25, 2003
- Drug Eleven Comes under the Aegis of Unizon Capital
August 25, 2003
- Korosho to Review GCP-related Notifications
August 25, 2003
- Interstitial Pneumonia Caused by OTC Cold Remedies Cautioned: Safety Info
August 25, 2003
- White Paper Outlines Recent Moves in Pharma Affairs Administration
August 25, 2003
- OTC NEWS IN BRIEF
August 25, 2003
- Korosho Reviews Action Plan to Achieve Its Vision for Drug Industry
August 25, 2003
- WORLD NEWS IN BRIEF
August 25, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
